This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Jiangsu Simcere Pharmaceutical Co., Ltd, Simcere Bio-Pharmaceutical Technology., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Xiaofeng Zhao
Introduction
Xiaofeng Zhao is a prominent inventor based in Nanjing, China. He is known for his significant contributions to the field of immunology, particularly through his innovative patent related to antibodies.
Latest Patents
One of Xiaofeng Zhao's notable patents is the "Anti-TNFR2 antibody and use thereof." This invention provides an antibody or an antigen-binding fragment capable of specifically binding to TNFR2. The antibody is designed to regulate the function of immune cells and may serve as a medicament for treating diseases associated with immune-related disorders, such as tumors. Additionally, the patent includes a polynucleotide encoding the antibody and a pharmaceutical composition comprising the antibody or its binding fragment.
Career Highlights
Xiaofeng Zhao has worked with reputable companies in the pharmaceutical sector, including Simcere Bio-Pharmaceutical Technology, Ltd. and Jiangsu Simcere Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Xiaofeng Zhao has collaborated with notable colleagues, including Xinyan Zhao and Shiqiang Lu. Their combined expertise has fostered innovation in the field of biotechnology.
Conclusion
Xiaofeng Zhao's contributions to immunology through his patent on the Anti-TNFR2 antibody highlight his role as a key innovator in the pharmaceutical industry. His work continues to influence the development of treatments for immune-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile